Advanced Medical Solutions Group annual ebitda
2022
2023
2024
2025
Advanced Medical Solutions Group's calculated EBITDA was £44.0M for fiscal 2025.
View full Advanced Medical Solutions Group company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £44.0M | £14.5M | +48.96% |
| 2024 | 2024-12-31 | £29.5M | −£2.8M | −8.67% |
| 2023 | 2023-12-31 | £32.3M | −£2.8M | −7.95% |
| 2022 | 2022-12-31 | £35.1M | — | — |
Between the periods ended 2022-12-31 and 2025-12-31, Advanced Medical Solutions Group's ebitda increased from £35.1M to £44.0M, a change of £8.9M.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Advanced Medical Solutions Group source filings ↗